Literature DB >> 10776749

Sleep attacks (sleep episodes) with pergolide.

A H Schapira.   

Abstract

Increased sedation, somnolence, and sleep episodes seem to occur with several, if not all, dopamine agonists and dopaminergic treatment. Patients at risk of sleep episodes can be identified by well-chosen questions, and could be managed by appropriate measures including dose reduction.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10776749     DOI： 10.1016/S0140-6736(00)02118-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  21 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

2.  Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.

Authors:  M Etminan; A Samii; B Takkouche; P A Rochon
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

Review 4.  Sleep disorders in patients with Parkinson's disease: epidemiology and management.

Authors:  J P Larsen; E Tandberg
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

Review 6.  How vital is sleep in Huntington's disease?

Authors:  Anna O G Goodman; Roger A Barker
Journal:  J Neurol       Date:  2010-03-24       Impact factor: 4.849

Review 7.  Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 8.  Sleep attacks in patients taking dopamine agonists: review.

Authors:  Carl Nikolaus Homann; Karoline Wenzel; Klaudia Suppan; Gerd Ivanic; Norbert Kriechbaum; Richard Crevenna; Erwin Ott
Journal:  BMJ       Date:  2002-06-22

Review 9.  'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?

Authors:  K Ray Chaudhuri; Suvankar Pal; Christine Brefel-Courbon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.

Authors:  Joëlle Micallef; Marc Rey; Alexandre Eusebio; Christine Audebert; Frank Rouby; Elisabeth Jouve; Sophie Tardieu; Oliver Blin
Journal:  Br J Clin Pharmacol       Date:  2008-09-19       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.